Endometrial Carcinoma Recruiting Phase 2 / 3 Trials for Topotecan (DB01030)

Also known as: Cancer of Endometrium / Endometrial Ca / Endometrial carcinoma (NOS) / Carcinoma endometrial / Ca endometrium / Endometrial cancer NOS / Endometrial cancer

IndicationStatusPhase
DBCOND0031833 (Endometrial Carcinoma)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02584478Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)Treatment